Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis
JAMA Dermatology · 04.11.2026
DOI: 10.1001/jamadermatol.2026.4305 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, online erschienen am 04.11.2026. Verfasst von Krithika Nayudu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Georgia, Augusta. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This research assesses nemolizumab effectiveness and safety for treatment of severe pruritus in patients with cutaneous T-cell lymphoma.
Autor:innen und Institutionen
- Medical College of Georgia, Augusta.
- Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
- Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
- Harvard Medical School, Boston, Massachusetts.
- Department of Dermatology, Massachusetts General Hospital, Boston.
Zitieren
APA
Nayudu, K., Vasavda, C., Buckhoree, F., Kupper, T., Shahriari, N., Chen, S., Meltzer, R., Stephen, S., & Larocca, C. (2026). Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2026.4305
Vancouver
Nayudu K, Vasavda C, Buckhoree F, Kupper T, Shahriari N, Chen S, et al. Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis. JAMA Dermatology. 2026. doi:10.1001/jamadermatol.2026.4305
BibTeX
@article{Nayudu2026,
author = {Nayudu, Krithika and Vasavda, Chirag and Buckhoree, Farrah and Kupper, Thomas and Shahriari, Neda and Chen, Steven and Meltzer, Rachel and Stephen, Sasha and Larocca, Cecilia},
title = {Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis},
journal = {JAMA Dermatology},
year = {2026},
doi = {10.1001/jamadermatol.2026.4305}
}
EUVIMED